Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India · Delayed Price · Currency is INR 363.10
+6.00 (1.68%)
May 22, 2026, 3:29 PM IST
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 40.19 billion as of May 22, 2026. Its market cap has increased by 35.11% in one year.
Market Cap
40.19B
Enterprise Value
40.81B
Revenue
1.59B
Ranking
n/a
PE Ratio
84.10
Stock Price
363.10
Market Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 40.19B, an increase of 115,394.08%. That is a compound annual growth rate of 33.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 40.19B | -16.63% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 79.62B |
| Sudeep Pharma | 76.05B |
| Sun Pharma Advanced Research Company | 68.07B |
| Aarti Pharmalabs | 63.78B |
| Innova Captab | 48.54B |
| RPG Life Sciences | 37.94B |
| Orchid Pharma | 35.83B |
| Solara Active Pharma Sciences | 27.18B |